Brief: Solara Active Pharma Sciences Says Board Approved Amalgamation Of Aurore, Empyrean And Hydra With Co
April 9 (Reuters) - Solara Active Pharma Sciences Ltd
SOLA.NS :
* SOLARA ACTIVE PHARMA SCIENCES - BOARD APPROVED
AMALGAMATION OF
AURORE, EMPYREAN AND HYDRA WITH CO
* SOLARA ACTIVE PHARMA SCIENCES - MERGER IS EPS ACCRETIVE
FROM
FY22
* SOLARA ACTIVE PHARMA SCIENCES LTD - AURORE TO MERGE WITH
SOLARA
IN AN ALL-STOCK TRANSACTION
* SOLARA ACTIVE PHARMA SCIENCES - AURORE SHAREHOLDERS TO
HAVE 27%
EQUITY HOLDING IN SOLARA MERGED ENTITY
Source text for Eikon: ID:nBSEcfs5rR
Further company coverage: SOLA.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Solara Active Pharma Sciences
See all newsIndia's Solara Active Pharma Sciences rises after quarterly profit
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees